ABRYSVO|RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF|305 |Pfizer, Inc|PFR |Active|Active|2023/07/12| ACAM2000|vaccinia (smallpox)|75 |Acambis, Inc|ACA |Inactive|Inactive|2010/05/28| ACAM2000|vaccinia (smallpox)|75 |Emergent BioSolutions|MIP |Active|Active|2022/06/10| ACEL-IMUNE|DTaP|20 || |Inactive|Inactive|2010/09/01| ACTHIB|Hib (PRP-T)|48 |Sanofi Pasteur|PMC |Active|Active|2010/05/28| ADACEL|Tdap|115 |Sanofi Pasteur|PMC |Active|Active|2010/05/28| Adenovirus types 4 and 7|Adenovirus types 4 and 7|143 |TEVA Pharmaceuticals USA |TVA |Active|Active|2019/07/23| Adenovirus types 4 and 7|Adenovirus types 4 and 7|143 |Barr Laboratories|BRR |Inactive|Inactive|2019/07/30| Afluria|Influenza, seasonal, injectable|141 |Seqirus|SEQ |Active|Active|2016/09/26| AFLURIA|Influenza, seasonal, injectable|141 |bioCSL|CSL |Inactive|Inactive|2016/09/26| Afluria quadrivalent preservative free|influenza, injectable, quadrivalent, preservative free|150 |Seqirus|SEQ |Active|Active|2016/10/04| Afluria quadrivalent, preservative free, pediatric|Influenza, injectable,quadrivalent, preservative free, pediatric|161 |Seqirus|SEQ |Active|Active|2019/08/26| Afluria, preservative free|Influenza, seasonal, injectable, preservative free|140 |bioCSL|CSL |Inactive|Inactive|2022/12/15| Afluria, preservative free|Influenza, seasonal, injectable, preservative free|140 |Seqirus|SEQ |Active|Inactive|2022/12/15| Afluria, quadrivalent|influenza, injectable, quadrivalent|158 |Seqirus|SEQ |Active|Active|2016/10/04| AGRIFLU|Influenza, seasonal, injectable, preservative free|140 |Novartis Pharmaceutical Corporation|NOV |Inactive|Inactive|2017/11/15| Arexvy|RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF|303 |GlaxoSmithKline|SKB |Active|Active|2023/07/12| AS03 adjuvant|AS03 Adjuvant|801 |GlaxoSmithKline|SKB |Active|Inactive|2015/09/11| AstraZeneca COVID-19 Vaccine (Non-US tradenames include VAXZEVRIA, COVISHIELD)|COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL|210 |AstraZeneca|ASZ |Active|Active|2022/10/18| ATTENUVAX|measles|05 |Merck and Co., Inc.|MSD |Active|Inactive|2015/04/28| Bexsero|meningococcal B, OMV|163 |GlaxoSmithKline|SKB |Active|Active|2016/03/22| Bexsero|meningococcal B, OMV|163 |Novartis Pharmaceutical Corporation|NOV |Inactive|Active|2015/02/02| BEYFORTUS|RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months|307 |Sanofi Pasteur|PMC |Active|Active|2023/07/21| BEYFORTUS|RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months|306 |Sanofi Pasteur|PMC |Active|Active|2023/07/21| BIAVAX II|rubella/mumps|38 || |Inactive|Inactive|2010/09/01| BIOTHRAX|Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis|24 |Emergent BioSolutions|MIP |Active|Active|2013/08/09| BOOSTRIX|Tdap|115 |GlaxoSmithKline|SKB |Active|Active|2010/05/28| CERTIVA|DTaP|20 || |Inactive|Inactive|2010/09/01| CERVARIX|HPV, bivalent|118 |GlaxoSmithKline|SKB |Active|Inactive|2016/11/22| COMIRNATY|COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose|208 |Pfizer, Inc|PFR |Active|Active|2023/09/06| COMIRNATY|COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose|217 |Pfizer, Inc|PFR |Active|Active|2023/09/06| COMIRNATY|COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL|309 |Pfizer, Inc|PFR |Active|Active|2023/09/06| COMVAX|Hib-Hep B|51 |Merck and Co., Inc.|MSD |Active|Inactive|2016/03/11| CONVIDECIA (CanSino Biologics) COVID-19 Vaccine|COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology|506 |CanSino Biologics, Inc|CAN |Active|Active|2022/11/01| Coronavac (Sinovac) COVID-19 Vaccine|COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)|511 |Sinovac |SNV |Active|Active|2021/07/13| COVAXIN (Bharat) COVID-19 Vaccine|COVID-19 IV Non-US Vaccine (COVAXIN)|502 |Bharat Biotech International Limited|BBI |Active|Active|2022/11/01| Covifenz|SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)|512 |Medicago, Inc|MDO |Active|Active|2022/04/11| CYFENDUS|Anthrax, post-exposure prophylaxis|318 |Emergent BioSolutions|MIP |Active|Active|2023/11/02| DAPTACEL|DTaP, 5 pertussis antigens|106 |Sanofi Pasteur|PMC |Active|Active|2010/05/28| DECAVAC|Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed|113 |Sanofi Pasteur|PMC |Active|Inactive|2017/10/27| DENGVAXIA|dengue fever tetravalent|56 |Sanofi Pasteur|PMC |Active|Active|2019/09/04| DRYVAX|vaccinia (smallpox)|75 || |Inactive|Inactive|2010/09/01| DT(GENERIC)|DT (pediatric)|28 |Sanofi Pasteur|PMC |Active|Active|2010/05/28| ENGERIX B-PEDS|Hep B, adolescent or pediatric|08 |GlaxoSmithKline|SKB |Active|Active|2013/08/09| ENGERIX-B-ADULT|Hep B, adult|43 |GlaxoSmithKline|SKB |Active|Active|2010/05/28| ERVEBO (Ebola Zaire Vaccine, Live)|Ebola Zaire vaccine, live, recombinant, 1mL dose|204 |Merck and Co., Inc.|MSD |Active|Active|2023/01/12| Fluad|influenza, trivalent, adjuvanted|168 |Seqirus|SEQ |Active|Active|2016/08/09| Fluad|influenza, trivalent, adjuvanted|168 |Novartis Pharmaceutical Corporation|NOV |Inactive|Active|2016/08/09| FLUAD Quadrivalent|Influenza vaccine, quadrivalent, adjuvanted|205 |Seqirus|SEQ |Active|Active|2020/07/20| FLUARIX|Influenza, seasonal, injectable, preservative free|140 |GlaxoSmithKline|SKB |Active|Inactive|2022/12/15| Fluarix, quadrivalent, preservative free|influenza, injectable, quadrivalent, preservative free|150 |GlaxoSmithKline|SKB |Active|Active|2013/08/09| Flublok|influenza, recombinant, injectable, preservative free|155 |Protein Sciences|PSC |Active|Active|2013/05/28| Flublok quadrivalent|influenza, recombinant, quadrivalent,injectable, preservative free|185 |Protein Sciences|PSC |Active|Inactive|2019/05/02| Flublok quadrivalent|influenza, recombinant, quadrivalent,injectable, preservative free|185 |Sanofi Pasteur|PMC |Active|Active|2019/05/02| Flucelvax|Influenza, injectable, MDCK, preservative free|153 |Novartis Pharmaceutical Corporation|NOV |Inactive|Inactive|2016/06/24| flucelvax, quadrivalent, preservative free|Influenza, injectable, MDCK, preservative free, quadrivalent|171 |Seqirus|SEQ |Active|Active|2016/06/16| Flucelvax, quadrivalent, with preservative|Influenza, injectable, MDCK, quadrivalent, preservative|186 |Seqirus|SEQ |Active|Active|2017/06/27| FLULAVAL|Influenza, seasonal, injectable|141 |ID Biomedical|IDB |Active|Active|2013/09/10| Flulaval quadrivalent|influenza, injectable, quadrivalent|158 |ID Biomedical|IDB |Active|Active|2013/09/10| Flulaval, preservative free|Influenza, seasonal, injectable, preservative free|140 |ID Biomedical|IDB |Active|Inactive|2022/12/15| Flulaval, quadrivalent, preservative free|influenza, injectable, quadrivalent, preservative free|150 |ID Biomedical|IDB |Active|Active|2014/10/21| FLUMIST|influenza, live, intranasal|111 |MedImmune, Inc. (AstraZeneca)|MED |Active|Inactive|2015/10/23| Flumist quadrivalent|influenza, live, intranasal, quadrivalent|149 |MedImmune, Inc. (AstraZeneca)|MED |Active|Active|2012/08/07| FLUVIRIN|Influenza, seasonal, injectable|141 |Novartis Pharmaceutical Corporation|NOV |Inactive|Active|2010/09/27| Fluvirin|Influenza, seasonal, injectable|141 |Seqirus|SEQ |Active|Active|2017/06/12| Fluvirin preservative free|Influenza, seasonal, injectable, preservative free|140 |Seqirus|SEQ |Active|Inactive|2022/12/15| FLUVIRIN-PRESERVATIVE FREE|Influenza, seasonal, injectable, preservative free|140 |Novartis Pharmaceutical Corporation|NOV |Inactive|Inactive|2022/12/15| FLUZONE|Influenza, seasonal, injectable|141 |Sanofi Pasteur|PMC |Active|Active|2010/09/27| FLUZONE High-Dose Quadrivalent|influenza, high-dose, quadrivalent|197 |Sanofi Pasteur|PMC |Active|Active|2020/01/29| FLUZONE High-Dose Quadrivalent Southern Hemisphere|influenza, Southern Hemisphere, high-dose, quadrivalent|231 |Sanofi Pasteur|PMC |Active|Active|2023/03/14| Fluzone Quad Intradermal|influenza, intradermal, quadrivalent, preservative free|166 |Sanofi Pasteur|PMC |Active|Inactive|2022/12/15| FLUZONE Quadrivalent Southern Hemisphere|influenza, Southern Hemisphere, preservative free|201 |Sanofi Pasteur|PMC |Active|Active|2020/03/12| FLUZONE Quadrivalent Southern Hemisphere|influenza, Southern Hemisphere, quadrivalent, with preservative|202 |Sanofi Pasteur|PMC |Active|Active|2020/03/12| FLUZONE Quadrivalent Southern Hemisphere, Pediatric|influenza, Southern Hemisphere, pediatric, preservative free|200 |Sanofi Pasteur|PMC |Active|Active|2020/04/21| Fluzone Quadrivalent, pediatric|Influenza, injectable,quadrivalent, preservative free, pediatric|161 |Sanofi Pasteur|PMC |Active|Active|2014/07/23| Fluzone, intradermal|influenza, seasonal, intradermal, preservative free|144 |Sanofi Pasteur|PMC |Active|Inactive|2022/12/15| Fluzone, Quadrivalent|influenza, injectable, quadrivalent|158 |Sanofi Pasteur|PMC |Active|Active|2013/08/08| Fluzone, quadrivalent, preservative free|influenza, injectable, quadrivalent, preservative free|150 |Sanofi Pasteur|PMC |Active|Active|2014/10/21| FLUZONE-HIGH DOSE|Influenza, high dose seasonal|135 |Sanofi Pasteur|PMC |Active|Active|2010/05/28| FLUZONE-PRESERVATIVE FREE|Influenza, seasonal, injectable, preservative free|140 |Sanofi Pasteur|PMC |Active|Inactive|2022/12/15| GARDASIL|HPV, quadrivalent|62 |Merck and Co., Inc.|MSD |Active|Inactive|2010/05/28| Gardasil 9|HPV9|165 |Merck and Co., Inc.|MSD |Active|Active|2014/12/11| HAVRIX-ADULT|Hep A, adult|52 |GlaxoSmithKline|SKB |Active|Active|2010/05/28| HAVRIX-PEDS|Hep A, ped/adol, 2 dose|83 |GlaxoSmithKline|SKB |Active|Active|2013/08/09| HEPLISAV-B|HepB-CpG|189 |Dynavax, Inc.|DVX |Active|Active|2017/10/27| HIBERIX|Hib (PRP-T)|48 |GlaxoSmithKline|SKB |Active|Active|2010/05/28| HIBTITER|Hib (HbOC)|47 || |Inactive|Inactive|2010/08/18| Imovax|rabies, intramuscular injection|18 |Sanofi Pasteur|PMC |Active|Inactive|2016/12/12| IMOVAX|Rabies - IM Diploid cell culture|175 |Sanofi Pasteur|PMC |Active|Active|2016/10/19| IMOVAX ID|rabies, intradermal injection|40 |Sanofi Pasteur|PMC |Active|Inactive|2016/11/22| INFANRIX|DTaP|20 |GlaxoSmithKline|SKB |Active|Active|2010/05/28| Influenza A (H5N1) -2013|Influenza A monovalent (H5N1), ADJUVANTED-2013|160 |ID Biomedical|IDB |Active|Active|2014/01/16| Influenza A monovalent (H5N1), ADJUVANTED-2013|Influenza A monovalent (H5N1), ADJUVANTED-2013|160 |GlaxoSmithKline|SKB |Active|Inactive|2015/08/27| IPOL|IPV|10 |Sanofi Pasteur|PMC |Active|Active|2010/05/28| IXCHIQ|Chikungunya live attenuated vaccine, 0.5 mL, PF|317 |Valneva|VAL |Active|Active|2023/12/14| IXIARO|Japanese Encephalitis IM|134 |Intercell Biomedical|INT |Inactive|Inactive|2016/07/19| Ixiaro|Japanese Encephalitis IM|134 |Valneva|VAL |Active|Active|2016/07/19| IXIARO|Japanese Encephalitis IM|134 |Vetter Pharma Fertigung GmbH & Co. KG|VET |Inactive|Active|2017/12/04| Janssen (J&J) COVID-19 Vaccine|COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL|212 |Janssen|JSN |Active|Active|2021/07/12| JE-VAX|Japanese encephalitis SC|39 |The Research Foundation for Microbial Diseases of Osaka University (BIKEN)|JPN |Inactive|Inactive|2015/04/29| JYNNEOS|Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection|206 |Bavarian Nordic A/S|BN |Active|Active|2022/05/20| KINRIX|DTaP-IPV|130 |GlaxoSmithKline|SKB |Active|Active|2010/05/28| MENACTRA|meningococcal MCV4P|114 |Sanofi Pasteur|PMC |Active|Active|2010/05/28| MENHIBRIX|Meningococcal C/Y-HIB PRP|148 |GlaxoSmithKline|SKB |Active|Inactive|2017/11/15| MENOMUNE|meningococcal MPSV4|32 |Sanofi Pasteur|PMC |Active|Inactive|2017/10/27| MenQuadfi|meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)|203 |Sanofi Pasteur|PMC |Active|Active|2020/05/27| Menveo|Meningococcal MCV4O|136 |GlaxoSmithKline|SKB |Active|Active|2016/03/22| MENVEO|Meningococcal MCV4O|136 |Novartis Pharmaceutical Corporation|NOV |Inactive|Active|2016/03/22| MERUVAX II|rubella|06 |Merck and Co., Inc.|MSD |Active|Inactive|2015/04/28| M-M-R II|MMR|03 |Merck and Co., Inc.|MSD |Active|Active|2010/05/28| Moderna COVID-19 Bivalent, Original + BA.1 (Non-US Tradename Spikevax Bivalent)|COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna|519 |Moderna US, Inc.|MOD |Active|Active|2022/11/17| Moderna COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename Spikevax Bivalent)|COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose|229 |Moderna US, Inc.|MOD |Active|Active|2022/11/16| Moderna COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename Spikevax Bivalent)|COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL|230 |Moderna US, Inc.|MOD |Active|Active|2022/11/16| Moderna COVID-19 Vaccine (non-US Spikevax)|COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose|221 |Moderna US, Inc.|MOD |Active|Active|2022/11/30| Moderna COVID-19 Vaccine (non-US Spikevax)|COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose|228 |Moderna US, Inc.|MOD |Active|Active|2022/11/30| Moderna COVID-19 Vaccine (non-US Spikevax)|COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose|207 |Moderna US, Inc.|MOD |Active|Active|2022/11/30| Moderna COVID-19 Vaccine (non-US Spikevax)|COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose|227 |Moderna US, Inc.|MOD |Active|Active|2022/11/30| Moderna COVID-19 Vaccine (US only)|COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL|311 |Moderna US, Inc.|MOD |Active|Active|2023/09/06| MUMPSVAX|mumps|07 || |Inactive|Inactive|2010/09/01| MYCOBAX|BCG|19 || |Inactive|Inactive|2015/12/11| Novavax COVID-19 Vaccine (Non-US Tradenames NUVAXOVID, COVOVAX)|COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL|211 |Novavax, Inc.|NVX |Active|Active|2022/11/16| Novavax COVID-19 Vaccine, Adjuvanted (US Only)|COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL|313 |Novavax, Inc.|NVX |Active|Active|2023/09/06| Novel influenza-H1N1-09|Novel influenza-H1N1-09|127 |Novartis Pharmaceutical Corporation|NOV |Inactive|Inactive|2015/08/27| Novel influenza-H1N1-09|Novel influenza-H1N1-09|127 |Sanofi Pasteur|PMC |Active|Inactive|2015/08/27| Novel influenza-H1N1-09|Novel influenza-H1N1-09|127 |bioCSL|CSL |Inactive|Inactive|2015/08/27| Novel Influenza-H1N1-09, nasal|Novel Influenza-H1N1-09, nasal|125 |MedImmune, Inc. (AstraZeneca)|MED |Active|Inactive|2015/08/27| Novel influenza-H1N1-09, preservative-free|Novel influenza-H1N1-09, preservative-free|126 |Sanofi Pasteur|PMC |Active|Inactive|2015/08/27| Novel influenza-H1N1-09, preservative-free|Novel influenza-H1N1-09, preservative-free|126 |bioCSL|CSL |Inactive|Inactive|2015/08/27| Novel influenza-H1N1-09, preservative-free|Novel influenza-H1N1-09, preservative-free|126 |Novartis Pharmaceutical Corporation|NOV |Inactive|Inactive|2015/08/27| OMNIHIB|Hib (PRP-T)|48 || |Inactive|Inactive|2010/09/01| ORIMUNE|OPV|02 || |Inactive|Inactive|2010/09/01| PEDIARIX|DTaP-Hep B-IPV|110 |GlaxoSmithKline|SKB |Active|Active|2010/05/28| PEDVAXHIB|Hib (PRP-OMP)|49 |Merck and Co., Inc.|MSD |Active|Active|2010/05/28| PENBRAYA|Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF|316 |Pfizer, Inc|PFR |Active|Active|2023/11/02| PENTACEL|DTaP-Hib-IPV|120 |Sanofi Pasteur|PMC |Active|Active|2010/05/28| Pfizer COVID-19 Bivalent, Original + BA.1 (Non-US Tradename COMIRNATY Bivalent)|COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech|520 |Pfizer, Inc|PFR |Active|Active|2022/11/17| Pfizer-BioNTech COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename COMIRNATY Bivalent)|COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose|300 |Pfizer, Inc|PFR |Active|Active|2022/11/16| Pfizer-BioNTech COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename COMIRNATY Bivalent)|COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose|302 |Pfizer, Inc|PFR |Active|Active|2022/11/16| Pfizer-BioNTech COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename COMIRNATY Bivalent)|COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose|301 |Pfizer, Inc|PFR |Active|Active|2022/11/16| Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled)|COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose|218 |Pfizer, Inc|PFR |Active|Active|2021/09/10| Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled)|COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose|217 |Pfizer, Inc|PFR |Active|Active|2021/09/10| Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled)|COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose|208 |Pfizer, Inc|PFR |Active|Active|2021/09/10| Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled)|COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose|219 |Pfizer, Inc|PFR |Active|Active|2021/09/10| Pfizer-BioNTech COVID-19 Vaccine (US Only)|COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL|308 |Pfizer, Inc|PFR |Active|Active|2023/09/06| Pfizer-BioNTech COVID-19 Vaccine (US Only)|COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL|310 |Pfizer, Inc|PFR |Active|Active|2023/09/06| PNEUMOVAX 23|pneumococcal polysaccharide PPV23|33 |Merck and Co., Inc.|MSD |Active|Active|2010/05/28| PREHEVBRIO Hepatitis B Vaccine (Recombinant)|HepB recombinant, 3-antigen, Al(OH)3|220 |VBI Vaccines, Inc|VBI |Active|Active|2022/01/25| PREVNAR 13|Pneumococcal conjugate PCV 13|133 |Wyeth|WAL |Active|Inactive|2010/05/28| PREVNAR 13|Pneumococcal conjugate PCV 13|133 |Pfizer, Inc|PFR |Active|Active|2010/05/28| PREVNAR 20|Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF|216 |Pfizer, Inc|PFR |Active|Active|2021/08/18| PREVNAR 7|pneumococcal conjugate PCV 7|100 |Wyeth|WAL |Active|Inactive|2015/09/24| PREVNAR 7|pneumococcal conjugate PCV 7|100 |Wyeth|WAL |Active|Inactive|2015/09/24| Priorix|MMR|03 |GlaxoSmithKline|SKB |Active|Active|2022/06/15| PROHIBIT|Hib (PRP-D)|46 || |Inactive|Inactive|2010/09/01| PROQUAD|MMRV|94 |Merck and Co., Inc.|MSD |Active|Active|2010/05/28| Quadracel|DTaP-IPV|130 |Sanofi Pasteur|PMC |Active|Active|2015/03/26| RABAVERT|Rabies - IM fibroblast culture|176 |GlaxoSmithKline|SKB |Active|Active|2016/10/19| RABAVERT|Rabies - IM fibroblast culture|176 |Novartis Pharmaceutical Corporation|NOV |Inactive|Inactive|2016/10/19| RabAvert|rabies, intramuscular injection|18 |Chiron Corporation|CHI |Inactive|Inactive|2016/03/22| RECOMBIVAX-ADULT|Hep B, adult|43 |Merck and Co., Inc.|MSD |Active|Active|2010/05/28| RECOMBIVAX-DIALYSIS|Hep B, dialysis|44 |Merck and Co., Inc.|MSD |Active|Active|2013/08/09| RECOMBIVAX-PEDS|Hep B, adolescent or pediatric|08 |Merck and Co., Inc.|MSD |Active|Active|2013/08/09| ROTARIX|rotavirus, monovalent|119 |GlaxoSmithKline|SKB |Active|Active|2010/05/28| ROTATEQ|rotavirus, pentavalent|116 |Merck and Co., Inc.|MSD |Active|Active|2010/05/28| Sanofi COVID-19 |COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL|225 |Sanofi Pasteur|PMC |Active|Active|2022/10/18| Sanofi COVID-19 |COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL|226 |Sanofi Pasteur|PMC |Active|Active|2022/10/18| SHINGRIX|zoster recombinant|187 |GlaxoSmithKline|SKB |Active|Active|2017/10/27| Sinopharm (BIBP) COVID-19 Vaccine|COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)|510 |Sinopharm-Biotech|SPH |Active|Active|2021/07/13| SPIKEVAX|COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL|312 |Moderna US, Inc.|MOD |Active|Active|2023/09/06| SPIKEVAX|COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose|207 |Moderna US, Inc.|MOD |Active|Active|2023/09/06| Stamaril|Yellow fever vaccine live - alt|183 |Sanofi Pasteur|PMC |Active|Active|2017/03/02| Td, adsorbed |Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed|09 |Grifols|GRF |Active|Inactive|2019/05/21| Td, adsorbed|Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed|09 |Massachusetts Biologic Laboratories|MBL |Active|Inactive|2019/05/21| TDVAX|Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed|09 |Massachusetts Biologic Laboratories|MBL |Active|Active|2019/05/21| Tenivac|Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed|113 |Sanofi Pasteur|PMC |Active|Active|2013/08/09| TETANUS TOXOID (GENERIC)|tetanus toxoid, adsorbed|35 |Sanofi Pasteur|PMC |Active|Inactive|2010/05/28| TETRAMUNE|DTP-Hib|22 || |Inactive|Inactive|2010/09/01| TICE BCG|BCG|19 |Merck and Co., Inc.|MSD |Active|Active|2021/07/26| TICOVAC|Tick-borne encephalitis, inactivated, PF, 0.5mL|224 |Pfizer, Inc|PFR |Active|Active|2021/11/04| TICOVAC|Tick-borne encephalitis, inactivated, PF, 0.25mL|223 |Pfizer, Inc|PFR |Active|Active|2021/11/04| TRIHIBIT|DTaP-Hib|50 |Sanofi Pasteur|PMC |Active|Inactive|2017/03/21| TRIPEDIA|DTaP|20 |Sanofi Pasteur|PMC |Active|Inactive|2017/11/15| Trumenba|meningococcal B, recombinant|162 |Pfizer, Inc|PFR |Active|Active|2014/11/03| TWINRIX|Hep A-Hep B|104 |GlaxoSmithKline|SKB |Active|Active|2010/05/28| TYPHIM VI|typhoid, ViCPs|101 |Sanofi Pasteur|PMC |Active|Active|2010/05/28| TYPHOID-AKD|typhoid, parenteral, AKD (U.S. military)|53 || |Inactive|Inactive|2013/08/09| VAQTA-ADULT|Hep A, adult|52 |Merck and Co., Inc.|MSD |Active|Active|2010/05/28| VAQTA-PEDS|Hep A, ped/adol, 2 dose|83 |Merck and Co., Inc.|MSD |Active|Active|2013/08/09| VARIVAX|varicella|21 |Merck and Co., Inc.|MSD |Active|Active|2010/05/28| VAXCHORA|cholera, live attenuated|174 |Emergent Travel Health, Inc (Formerly PaxVax)|PAX |Active|Active|2016/06/17| VAXELIS|DTaP,IPV,Hib,HepB|146 |MSP Vaccine Company - (partnership Merck and Sanofi Pasteur)|MSP |Active|Active|2021/07/21| VAXNEUVANCE|Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF|215 |Merck and Co., Inc.|MSD |Active|Active|2021/08/18| Vivotif|typhoid, oral|25 |Emergent Travel Health, Inc (Formerly PaxVax)|PAX |Active|Active|2021/07/23| VIVOTIF BERNA|typhoid, oral|25 |Crucell|CRU |Inactive|Inactive|2016/05/02| YF-VAX|yellow fever live|37 |Sanofi Pasteur|PMC |Active|Active|2010/05/28| ZOSTAVAX|zoster live|121 |Merck and Co., Inc.|MSD |Active|Active|2010/05/28|